Physiotherapists increasingly manage shoulder referrals in place of orthopaedic doctors. Better understanding the agreement between these professionals will help inform the safety, quality and potential costs of these care models.
BACKGROUND
Musculoskeletal disorders are the second largest cause of global disability (Vos et al. 2012) , with prevalence expected to increase as the population ages (Murray et al. 2012 ). As publicly funded health services face growing challenges (Australian Government Productivity Commission 2011; Department of Health 2006; The Kings Fund 2015) , orthopaedic screening services increasingly provide early access to experienced physiotherapists (Comans et al. 2014; Desmeules et al. 2012; Stanhope et al. 2012 ) for assessment and non-surgical management. As the second to third most prevalent musculoskeletal disorder (Parsons et al. 2007; Picavet and Schouten 2003; Taylor 2005; Urwin et al. 1998 ), shoulder pain is frequently referred for orthopaedic opinion (Buchbinder et al. 2013; Dorrestijn et al. 2011; Linsell et al. 2006 ) and often seen by physiotherapists in screening services (Queensland Health 2013) where decisions made by physiotherapists, rather than medical doctors, determine patient care. Consequently, information is needed about the level of similarity between physiotherapist and orthopaedic surgeon decisions, to better understand the safety, service quality and potential costs of emerging models of care in which patients are seen by physiotherapists instead of medical doctors.
Prior comparisons of physiotherapist and orthopaedic surgeon decision-making only partially represent emerging models of care, as they focused on less complex patients and neglected prescribing and corticosteroid injection. Physiotherapists and orthopaedic surgeons generally agree on hip and knee diagnosis and management (Aiken et al. 2008; Aiken and McColl 2008; Desmeules et al. 2013; MacKay et al. 2009 ), however all but one study (Aiken et al. 2008 ) excluded patients with higher comorbidity or complexity. Only two studies have investigated shoulder pain; one had only six shoulder participants (Aiken and McColl 2008) , the other reported a Kappa of 0.75 for surgical versus conservative management (Razmjou et al. 2013) and both excluded more complex cases with suggestion of infection, metabolic or inflammatory disease, masses, compensation claims or previous surgery. Therefore, no studies have yet compared the shoulder management decisions of a physiotherapist with those of an orthopaedic surgeon, across the range of presentations that might normally attend an orthopaedic outpatient clinic. This knowledge gap has important application to service design, regarding whether it is necessary for an orthopaedic doctor to review referrals to select which patients will be seen by a physiotherapist. A further knowledge gap relates to corticosteroid injection, a common non-surgical treatment for the most prevalent form of shoulder pain caused by subacromial pathologies (Diercks et al. 2014; Hambly et al. 2007; James et al. 2005; Jowett et al. 2013) . Presently physiotherapists are only permitted to train in prescribing and injection in the UK (UK Government 2013), with similar models under investigation in some other countries (Health Workforce Australia). No studies have yet investigated prescribing and injection decisions of medical doctors compared with physiotherapists trained in these procedures.
Therefore, we compared decisions made by a physiotherapist and a consultant orthopaedic surgeon in a representative sample of adult shoulder pain referred by general practitioners to hospital orthopaedics. Primary aims were to assess agreement regarding patient management, selection for subacromial corticosteroid injection and injection safety, and describe the reasoning underpinning decision discrepancies. Secondary aims were to describe the level of diagnostic and investigation agreement.
METHODS

Design
A blinded inter-rater decision-making reliability study, as described in the published RCT protocol (XXXX et al. 2014) investigating XXXX, was undertaken on XXXX between January 2013 and June 2014. Agreement between the physiotherapist and orthopaedic surgeon was an RCT entry and we have separated the inter-rater decision-making analysis from the RCT to enable Other elements within this published protocol are reported separately. All participants provided written informed consent and were able to withdraw from the study at any point without impact upon their care.
Ethical approval
Ethical Approval was granted through the XXXX Human Research Ethics Committee, NHMRC code EC00160 (HREC/12/QGC/30; SSA/12/QGC/97), and XXXX Human
Research Ethics Committee (MED/23/13/HREC). The trial was registered on the Australia and New Zealand Clinical Trials Registry XXXX
Participants
Adults aged 18 years or over with a new orthopaedic shoulder referral from a general practitioner (GP) were recruited from the waiting list, if they were able to read and understand the trial literature and provide informed consent, and excluded if they knew the assessing physiotherapist or orthopaedic surgeon (eg, from previous consultation) or had not received a plain radiograph (X-Ray) of their affected shoulder in the previous 12 months (in keeping with local referral guidelines).
Assessors
The physiotherapist (XX) had 19 years musculoskeletal experience including qualifications in injection therapy and UK Non-Medical Prescribing. The orthopaedic surgeon (XX) was a staff specialist with 20 years of experience and a Fellow of the UK Royal College of Surgeons.
Centres
All participants were seen in orthopaedic outpatient settings, at XXXX.
Intervention (clinical assessments)
After the research assistant gained consent, all participants were independently examined the physiotherapist and the orthopaedic surgeon in variable order according to assessor availability. Patients were allocated 30 minutes with each assessor with the same information; the orthopaedic referral, the electronic hospital record, shoulder X-ray report, other results such as diagnostic imaging films and/or reports (MRI, CT, ultrasound scans) or pathology results that participants brought to the consultation. Each assessor performed a clinical assessment (history and physical examination) and completed a standardised assessment form for each participant, which was returned to the research assistant upon completion.
Blinding
Participants were blind to the profession of their assessors (i.e. they did not know which clinician was the physiotherapist and which was the surgeon), and were 
Sample size
Sample size calculations for the randomised controlled trial within the published protocol (XXXX et al. 2014) , assumed , with a sample of 64 participants required for the RCT. We anticipated that 25% of all participants assessed, would enter the RCT. As all assessed participants would be eligible for the present agreement study, 256 were expected and 274 participants were ultimately recruited. This number exceeds the largest number of subjects (n=100) previously reported by an inter-rater orthopaedic and physiotherapy agreement study (Razmjou et al. 2013) . It also exceeds the number required to detect Kappa values over 0.6 with 90% power, assuming a null of Kappa = 0.4 (Sim and Wright 2005) , and the number required for agreement proportions of 30% to 100%, with a relative error of 20% (Gwet 2010) .
Data analysis
Data were analysed using SPSS software version 22 (IBM, Chicago USA), AgreeStat 2013.4, and AgreeStat 2015.5 for Excel (Advanced Analytics; Gaithersburg, MD, USA). Accuracy of the free text coding was assessed by two investigators (XX, XX), and at the completion of data entry the accuracy of the data entries ensured through comparison of the hard copy data and the data on the electronic database for 30 participants (every tenth participant), by one investigator (XX). Descriptive statistics were used to describe baseline characteristics. Four agreement coefficients were calculated for primary and secondary outcomes, to assess the level of agreement (inter-rater reliability) between the physiotherapist and the orthopaedic 
Primary Outcomes
Management decisions:
There was near perfect agreement regarding initial management with surgery versus non-surgical care (Table 2) , with the artificially low C K a result of prevalence bias from high non-surgical agreement at 253 / 274, (Table 3 ). In the eight cases in which the surgeon said no to initial non-surgical care but the physiotherapist said yes, the physiotherapist also recommended orthopaedic review for surgery in four cases, and MRI in the other four. Conversely in nine cases the physiotherapist felt orthopaedic review was needed and said no to initial nonsurgical care but the surgeon said yes. In seven of these the surgeon opted for corticosteroid injection and recorded that surgery would be likely if response to injection was insufficient. In the remaining two cases the surgeon wanted to trial physiotherapy initially. Physiotherapy was the most frequent treatment recommendation by both assessors (223/ 274 cases). Overall, the physiotherapist recommended physiotherapy treatment in 86% of cases, and the surgeon in 91% of cases. Injection decisions:
There was substantial to near perfect agreement regarding whether it was safe to inject ( Table 2) . Of the 36 cases in which the surgeon felt it was unsafe to inject on the day of assessment, the physiotherapist reached the same conclusion in 35 (Table   4 ). In the one remaining case, the patient reported being well but test results from recent endoscopy were not available on the day of assessment. The physiotherapist rated this as a precaution rather than a contraindication to injection. Conversely in 28 cases the physiotherapist perceived a safety barrier yet the surgeon felt it would be safe to inject. The infection (such as skin, dental, urinary or other) needing further medical review before injection (N=20), possible need for prophylactic antibiotics prior to injection due to a prosthetic heart valve (N=3), history of possible fracture (N=2), and poor diabetic control (N=1). There were substantial levels of agreement on the presence or absence of symptoms to support the use of subacromial injection ( (Table 4 ). There were 14 cases of disagreement, in which the T cases of dual pathology in which the surgeon chose to inject another structure over the subacromial space as first priority (long head of biceps sheath in six cases, acromioclavicular joint in two cases); in four cases the surgeon referred for initial physiotherapy; and two cases the surgeon requested MRI in the first instance.
Conversely there were 62 cases in which the surgeon opted to provide same-day subacromial injection but the physiotherapist did not. A detailed breakdown of the reasons is contained in Table 5 . Cuff tear for MRI +/-surgical consideration (7) MRI shoulder due to diagnostic uncertainty (4) MRI cervical spine (1) Stable shoulder fracture present, for orthopaedic opinion (1) Presentation not likely to respond to subacromial injection 5
Significant rotator cuff tear (2) Long head of biceps pain source (1) Osteoarthritis too significant (1) Cervical spine cause (1) Other injection is higher priority 5
Long head of biceps sheath (5) Consent not gained 4 Patient declined injection when offered by physiotherapist (4) Possible inflammatory pathology 3
Blood tests +/-rheumatology referral (3)
Secondary Outcomes
Investigation requests revealed near perfect agreement (AC1=.87) by type (Table 2) , and similar volume ( 
Diagnosis:
Overall, there was substantial agreement (AC1=0.72) between the two assessors on categorised primary shoulder pain diagnoses ( Table 2 ). The frequencies with which each assessor recorded primary diagnoses in each of the eight diagnostic categories, and the agreement between assessors are detailed in Table 7 . Subacromial impingement was the most common primary diagnosis, made by the orthopaedic surgeon in 188 cases, the physiotherapist in 170 cases, with agreement in 148 cases.
Other primary diagnoses were recorded less frequently, with varying levels of agreement as detailed in Table 7 . 
DISCUSSION
Results demonstrate that the physiotherapist makes safe and very similar decisions to the orthopaedic surgeon in relation to care delivery, prescription of corticosteroid injection, investigation and diagnosis. These findings provide preliminary support for agreement between these two professions and have relevance to models of care which complement or substitute medical doctors with physiotherapists to improve access for patients, service productivity and workforce shortages (Brooks, Robinson, and Ellis 2008; Comans et al. 2014; Duckett 2005) . In previous studies orthopaedic doctors first screened referrals to exclude more complex patients and/or those thought more likely to need surgery (Aiken and McColl 2008; Bornhöft, Larsson, and Thorn 2015; Daker-White et al. 1999; Ludvigsson et al. 2011; MacKay et al. 2009; Samsson and Larsson 2014; Weale and Bannister 1995) . We did not exclude more complex referrals and therefore our results indicate that an experienced physiotherapist can safely and appropriately manage the breadth of GP orthopaedic shoulder referrals, suggesting that screening of referrals by orthopaedic doctors prior to physiotherapist assessment may be unnecessary.
Previously physiotherapists have more frequently recommended education and physiotherapy exercises than orthopaedic doctors (Aiken et al. 2008; Daker-White et al. 1999; Desmeules et al. 2013 ), yet we found near perfect agreement and minimal overall difference in the rate of referral to physiotherapy. Our findings of lower injection recommendation rates by the physiotherapist contrast with two previous studies (Desmeules et al. 2013; Razmjou et al. 2013) . However, ours is the first study to investigate this with a physiotherapist qualified to inject and prescribe.
Agreement was near perfect regarding the safety aspects of injection and substantial regarding the presence of subacromial symptoms. Whilst still moderate, agreement was less regarding whether to deliver an immediate injection, with 14/274 cases in which the physiotherapist chose to inject but the surgeon did not, and 62/274 cases in which the surgeon chose to immediately inject but the physiotherapist did not; few of which were due to disagreement about whether the presentation may be amenable to subacromial injection, but rather reflected different prioritisation of non-surgical treatment options, with the physiotherapist less inclined than the surgeon to start with corticosteroid injection (Table 5 ). We consider this more conservative approach to injection by the physiotherapist to be appropriate, and further research could establish whether this finding is a consistent feature of physiotherapy prescribing / injection practice.
This study has some limitations. Generalizability is limited with just one orthopaedic surgeon and one physiotherapist. While this is consistent with previously published shoulder decision-making comparisons (Aiken and McColl 2008; Razmjou et al. 2013) , it means that specific findings may have limited generalizability beyond this study. The use of only one physiotherapist was due to the study protocol (XXXX et al. 2014) including injection by a physiotherapist (reported separately), and as this is not normally permitted in Australia, additional qualified physiotherapists were not available. Future research with more professionals could verify our findings. Furthermore, intra-professional decision-making has not previously been reported, and this could provide a more robust basis for inter-professional comparison. A second limitation was the exclusion of participants without a reported X-Ray less than 12 months old. This met departmental referral requirements and helped prevent clinic delays but also reduced the need for assessors to interpret unreported imaging. Thirdly, we were unable to formally randomize the order of the participant examination (physiotherapist or surgeon first) due to the practicalities of room availability in an outpatient clinic setting. Instead, participants were pseudorandomized according to which health practitioner was first available at the time of their appointment. Whilst appointments were allocated on a 30-minute basis, we did not record actual consultation times. A final limitation is that the collection of followup clinical outcomes was beyond the scope of the present study. This data could provide further insight, particularly in cases of assessor disagreement.
In conclusion, this study compared one experienced physiotherapist qualified in prescribing and corticosteroid injection, with one orthopaedic surgeon and found near perfect agreement between the two regarding clinical decision making (investigation, surgical or non-surgical management and subacromial corticosteroid injection safety) for shoulder patients referred to an Australian public hospital orthopaedic department. There were differences in the priority given to different non-surgical treatment options, with a more conservative approach by the physiotherapist regarding subacromial corticosteroid injection as the first and immediate treatment. This study suggests that screening of referrals by orthopaedic doctors prior to assessment by a suitably qualified physiotherapist may be unnecessary, and found no clinical, safety or cost basis for legislative or funding policy impediments to appropriately trained physiotherapists selecting and referring shoulder pain patients for subacromial corticosteroid injection. 
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